Chelsea Therapeutics (CHTP) Tops Q2 EPS by 4c
- Top 10 News for 7/25 - 7/29: Earnings and Mergers and ... Chioptle Making Burgers?
- Tech shares and muted GDP growth push S&P 500 to record
- No clean bill of health for EU banks in stress test
- Private equity firms focused on Hewlett Packard asset sales: sources
- Tesla (TSLA) Gains as Panasonic Seeks to Raise $3.9B for Gigafactory
Chelsea Therapeutics (NASDAQ: CHTP) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LifePoint Health (LPNT) Misses Q2 EPS by 19c, Guidance Falls Short
- Alphabet and Amazon wind up stellar quarter for big tech
- Forestar Group (FOR) Tops Q2 EPS by 13c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!